Our functional hydrogel, composed of GH-GMA loaded with IL-2 and VEGF-C encapsulating T-LEC spheroids, holds promise as a fundamental platform for cancer immunotherapy, such as immune checkpoint inhibitors, or for engineering platforms to modulate the suppressive TME. This evidence concerns the gene IL2 and cancer.